U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07530965) titled 'OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE' on March 16.
Brief Summary: The purpose of this feasibility study is to investigate the role of a dietary supplement in modulating the gut microbiota and improving pain outcomes in children with sickle cell disease (SCD).
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Sickle Cell Disease (SCD)
Intervention:
DIETARY_SUPPLEMENT: Flaxseed
Flaxseed
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Alabama at Birmingham
Information provided by (Responsible Party): Chinenye Dike, University of Alabama at Birmingham
Disclaimer: Curated by HT ...